Literature DB >> 6631068

Frequency of delta agent infections in Kuwait.

E Nordenfelt, B G Hansson, B Al-Nakib, S Al-Kandari, W Al-Nakib.   

Abstract

Antibodies to delta antigen have been found among all populations in the world studied so far. The prevalence is high (40%-47%) in chronic HBsAg carriers in southern Italy. In other parts of the world, the prevalence is low (less than 5%); however, 30%-75% of polytransfused hemophiliacs and drug addicts in Europe and the United States have antibodies to delta antigen [2]. Most Arab nationalities are well represented in the population of Kuwait. Among 144 HBsAg-positive sera studied, 58 (40%) were positive for antibodies to delta antigen. Data regarding diagnosis, age, sex, and nationality were available for 80 of the patients investigated. Among these, 32 (40%) were antibody-positive. The highest number of positive patients was among those with chronic liver disease; all except two of the positive patients were Gulf or Mediterranean Arabs. Thus, infection with delta agent is an important cofactor in the pathogenesis of chronic liver disease in this region, because delta agent is known to become chronic [2]. The patients who had chronic liver disease and those who had illnesses other than liver disease or acute hepatitis are probably all chronic HBsAg carriers; however, it was not possible to differentiate between chronic and transient carrier states. Some of the patients with acute hepatitis also probably carried HBsAg with a superimposed delta infection. The carriage rate of HBsAg in the normal population in Kuwait is 2.8%-4% [3]. The only fatal case of acute hepatitis in this study occurred among the patients who were positive for delta antibody.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6631068     DOI: 10.1093/infdis/148.4.768

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  7 in total

1.  Delta infection in eastern Sicily.

Authors:  A Smedile; M A Freni; L Caruso; A Ajello; C Trischitta; M L Resta; G Bertino; G Berlinghieri; S Rapisarda; L Di Geronimo
Journal:  Eur J Epidemiol       Date:  1987-12       Impact factor: 8.082

2.  Delta hepatitis virus infection in Ethiopia.

Authors:  M Rapicetta; K Hailu; A Ponzetto; C Hele; G Morace; D Bekura; L Bisanti; S Conti; P Pasquini; M Rizzetto
Journal:  Eur J Epidemiol       Date:  1988-06       Impact factor: 8.082

3.  Prevalence of antibody to delta hepatitis virus in population groups in West Germany and Switzerland.

Authors:  G G Frösner; E Franco; J Altorfer; R H Decker; I K Mushahwar
Journal:  Eur J Clin Microbiol       Date:  1985-04       Impact factor: 3.267

4.  Hepatitis delta infections.

Authors:  K G Nicholson
Journal:  Br Med J (Clin Res Ed)       Date:  1985-05-11

5.  A study on delta virus infection and its clinical impact in Iran.

Authors:  H Rezvan; B Forouzandeh; S Taroyan; S Fadaiee; F Azordegan
Journal:  Infection       Date:  1990 Jan-Feb       Impact factor: 3.553

6.  Epidemiology and clinical outcome of hepatitis D virus infection in Turkey.

Authors:  I Balik; M Onul; E Tekeli; F Caredda
Journal:  Eur J Epidemiol       Date:  1991-01       Impact factor: 8.082

7.  Prevalence of hepatitis d in the eastern mediterranean region: systematic review and meta analysis.

Authors:  Neda Amini; Seyed Moayed Alavian; Ali Kabir; Seyed Hossein Aalaei-Andabili; Seyed Yasser Saiedi Hosseini; Mario Rizzetto
Journal:  Hepat Mon       Date:  2013-01-06       Impact factor: 0.660

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.